CellGenix, a Freiburg, Germany-headquartered manufacturer of GMP-grade raw materials for cell therapy, gene therapy, and tissue-engineered products, has begun facility expansions for to meet product pipeline advancement into late-stage clinical development and commercialization.

Through early 2018, research and development laboratory as well as production and warehouse space will be added to its German headquarters in Freiburg. The upgrade will also include large-scale filling capacities for recombinant protein products in its existing GMP facilities.

Source: CellGenix